Siste måned

30 dager
0
NETTO POSISJON (NOK)
Handler
0
Kjøp
0
Salg
0

6 måneder

180 dager
+421 980
NETTO POSISJON (NOK)
Handler
1
Kjøp
421 980
Salg
0

Historikk

ℹ️ Om innsidehandel

Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.

Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.

Transaksjoner

Dato Innsider Antall Pris Verdi
27.02.2026
Nils Ole Krekling
Chief Financial Officer
19 627 21.50 421 980
07.10.2025
Astrid T. Bratvedt
Chief Scientific Officer
via Tranbergkollen Invest AS
25 000 21.50 537 500
07.10.2025
Jostein Davidsen
Chairperson of the board of directors
17 116 21.50 367 994
07.10.2025
Morten Jurs
Board member
via Jurs AS
7 851 21.50 168 796
07.10.2025
Kathrine Elisabeth Gamborg Andreassen
CEO
via Soleglad Invest AS
23 260 21.50 500 090
07.10.2025
Philip Slätis
Commercial Director RX & International
3 422 21.50 73 573
03.10.2025
Astrid T. Bratvedt
Chief Scientific Officer
via Tranbergkollen Invest AS
25 000 21.50 537 500
03.10.2025
Jostein Davidsen
Chairperson of the board of directors
17 116 21.50 367 994
03.10.2025
Morten Jurs
Board member
via Jurs AS
7 851 21.50 168 796
03.10.2025
Kathrine Elisabeth Gamborg Andreassen
CEO
via Soleglad Invest AS
23 260 21.50 500 090
03.10.2025
Philip Slätis
Commercial Director RX & International
3 422 21.50 73 573

Pressemeldinger

Dato Melding
27.02.2026
Navamedic ASA: Mandatory notification of trade
Oslo, 27 February 2026 - Nils Ole Krekling, CFO at Navamedic ASA, has bought 19,627 shares in Navamedic ASA at an average price of NOK 21.50 per share...
07.10.2025
Navamedic ASA: Allocation of shares in the rights issue to primary insiders and their close associates
Oslo, 7 October 2025: Reference is made to the stock exchange announcement published by Navamedic ASA (the "Company") earlier today regarding the fina...
03.10.2025
Navamedic ASA: Mandatory notification of trades by primary insiders and their close associates
Oslo, 3 October 2025: Reference is made to the stock exchange announcement published by Navamedic ASA (the "Company") on 22 September 2025, regarding ...